Dr. Huiping Liu | Antibody Therapeutic | Best Researcher Award
Northwestern University Feinberg | United States
Huiping Liu, MD, PhD, is a distinguished physician-scientist recognized for her pioneering contributions in cancer research, particularly in the fields of breast cancer biology, cancer stem cells, and chemoresistance. She earned her medical and master’s degrees from the Fourth Military Medical University and completed her doctoral studies in biomedical sciences at the University of Chicago. Furthering her training, she pursued postdoctoral research at Stanford University focusing on cancer stem cells in metastasis and later at the University of Chicago investigating microRNAs and chemoresistance. Professionally, she has held academic appointments at Case Western Reserve University before joining Northwestern University Feinberg School of Medicine, where she now serves as an associate professor with tenure, director of the Breast Cancer Research Program, and scientific director of the Circulating Tumor Cell Core. Her research interests include tumor heterogeneity, circulating tumor cells, microRNA regulation, drug resistance mechanisms, and translational approaches to improve cancer therapies. She is highly skilled in molecular oncology, genomics, stem cell biology, translational research, and mentoring emerging scientists. Her honors include recognition as a Chan Zuckerberg Biohub Investigator, membership in the American Society for Clinical Investigation, and multiple awards and research grants from leading organizations. Dr. Liu’s career reflects an enduring commitment to advancing cancer research, shaping future therapies, and training the next generation of scientists.
Profile: Google scholar
Featured Publications
Shimono, Y., Zabala, M., Cho, R. W., Lobo, N., Dalerba, P., Qian, D., Diehn, M., & Liu, H. (2009). Downregulation of miRNA-200c links breast cancer stem cells with normal stem cells. Cell, 138(3), 592–603. Citations: 1472.
Liu, H., Patel, M. R., Prescher, J. A., Patsialou, A., Qian, D., Lin, J., Wen, S., & colleagues. (2010). Cancer stem cells from human breast tumors are involved in spontaneous metastases in orthotopic mouse models. Proceedings of the National Academy of Sciences, 107(42), 18115–18120. Citations: 581.
Chen, W., Hoffmann, A. D., Liu, H., & Liu, X. (2018). Organotropism: new insights into molecular mechanisms of breast cancer metastasis. NPJ Precision Oncology, 2(1), 4. Citations: 428.
Liu, X., Taftaf, R., Kawaguchi, M., Chang, Y. F., Chen, W., Entenberg, D., Zhang, Y., & Liu, H. (2019). Homophilic CD44 interactions mediate tumor cell aggregation and polyclonal metastasis in patient-derived breast cancer models. Cancer Discovery, 9(1), 96–113. Citations: 389.
Bockhorn, J., Dalton, R., Nwachukwu, C., Huang, S., Prat, A., Yee, K., Chang, Y. F., & Liu, H. (2013). MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11. Nature Communications, 4(1), 1393. Citations: 282.